drugset / Trial / NCT02664805

Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema

NCT02664805

Phase 2 Completed 91 enrolled LEO Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To compare the efficacy of twice daily applications of LEO 124249 ointment with LEO 124249 ointment vehicle for up to 8 weeks in the treatment of subjects with chronic hand eczema.

Timeline

Start
2016-02
Primary completion
2016-07
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Delgocitinib Small molecule Topical

Indications

No indication recorded.